Meet the team behind our pioneering science
At BioMarin, we dare to engage in iterative processes of scientific inquiry in order to fundamentally improve the lives of patients.
BioMarin is home to a progressive team of world-recognised leaders in genomic, molecular, process, safety, and clinical sciences; visionaries in their fields who have been the first to discover and sequence genes like Factor VIII, invent technologies, introduce novel processes and assays, and characterise diseases.
Our comprehensive understanding of each biological pathway, from genotype to phenotype, allows us to creatively harness the most impactful methods of therapeutic intervention.
Learn more about the leaders who propel our scientific ingenuity, below.
Meet Our Scientific Leaders
-
Henry J. FuchsM.D., President, Worldwide Research and Development
-
Kevin EgganPh.D., Group Vice President, Head of Research and Early Development
-
Brinda BalakrishnanM.D., Ph.D., Senior Vice President, Chief Business Development Officer
-
Stephen ZoogPh.D., Vice President of Translational Sciences
-
Gordon VeharPh.D., Head of External Innovation
-
Charles A. O'NeillPh.D., Head of Early Drug Development Solutions
-
Jonathan DayMBBS, Ph.D., FFPM, FESC, MRCS, Vice President, Medical Director, Head of Global Clinical Sciences
-
Harold BernsteinM.D., Ph.D., Senior Vice President, Chief Medical Officer and Head of Global Clinical Development
-
Ganesh VedanthamPh.D., Senior Vice President, Technical Development
Meet the Fellows
A Fellow is the highest recognition that scientific researchers can receive at BioMarin, reflecting their direct contributions to the development of our marketed or pipeline therapies.
-
Stuart BuntingPh.D., Fellow, Head of Biology Research
-
David JacobyM.D., Ph.D., Fellow, Head of Discovery Medicine
-
Erno Pungor, Jr.Ph.D., Fellow, Analytical Chemistry
Manufacturing Excellence
We take pride in manufacturing complex therapies for the patients who need them most.
Learn More Manufacturing Excellence ⌃